Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease.

[1]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[2]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[3]  I. Adcock,et al.  T helper type 17‐related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients , 2009, Clinical and experimental immunology.

[4]  J. Domagala-Kulawik,et al.  Effects of cigarette smoke on the lung and systemic immunity. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[5]  V. Kuchroo,et al.  Role of Th1 and Th17 cells in organ-specific autoimmunity. , 2008, Journal of autoimmunity.

[6]  V. Kuchroo,et al.  Interplay Between Effector Th17 and Regulatory T Cells , 2008, Journal of Clinical Immunology.

[7]  V. Kim,et al.  New concepts in the pathobiology of chronic obstructive pulmonary disease. , 2008, Proceedings of the American Thoracic Society.

[8]  M. McGeachy,et al.  Review Th17 Cell Differentiation: the Long and Winding Road , 2022 .

[9]  L. Fouser,et al.  An IL-17F/A Heterodimer Protein Is Produced by Mouse Th17 Cells and Induces Airway Neutrophil Recruitment , 2007, The Journal of Immunology.

[10]  S. Hodge,et al.  Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects , 2007, Clinical and experimental immunology.

[11]  Dave Singh,et al.  CD4-regulatory cells in COPD patients. , 2007, Chest.

[12]  H. Coxson,et al.  Antielastin autoimmunity in tobacco smoking–induced emphysema , 2007, Nature Medicine.

[13]  Lawrence Steinman,et al.  A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.

[14]  A. Cabral,et al.  Autoimmune inflammation from the Th17 perspective. , 2007, Autoimmunity reviews.

[15]  K. Kikly,et al.  The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. , 2006, Current opinion in immunology.

[16]  A. Agustí,et al.  Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease , 2006, Clinical and experimental immunology.

[17]  J. Jardim,et al.  Valores de referencia espirométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 o más años de edad , 2006 .

[18]  G. Valdivia,et al.  [Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over]. , 2006, Archivos de bronconeumologia.

[19]  K. Murphy,et al.  Th17: an effector CD4 T cell lineage with regulatory T cell ties. , 2006, Immunity.

[20]  I. Adcock,et al.  Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.

[21]  D. Postma,et al.  Cigarette smoke-induced emphysema: A role for the B cell? , 2006, American journal of respiratory and critical care medicine.

[22]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[23]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[24]  John D. Mitchell,et al.  Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. , 2005, American journal of respiratory and critical care medicine.

[25]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[26]  Shau-ku Huang,et al.  Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. , 2005, American journal of respiratory and critical care medicine.

[27]  D. Corry,et al.  An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema , 2004, PLoS medicine.

[28]  S. Hodge,et al.  Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease , 2004, Cytometry. Part B, Clinical cytometry.

[29]  M. Cosio.  Autoimmunity, T‐cells and STAT‐4 in the pathogenesis of chronic obstructive pulmonary disease , 2004, European Respiratory Journal.

[30]  I. Adcock,et al.  STAT4 activation in smokers and patients with chronic obstructive pulmonary disease , 2004, European Respiratory Journal.

[31]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[32]  M. Cosio,et al.  Hypothesis: Does COPD have an autoimmune component? , 2003, Thorax.

[33]  Y. Ho,et al.  Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.

[34]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[35]  Katie Chan,et al.  Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. , 2002, American journal of respiratory cell and molecular biology.

[36]  M. Cosio,et al.  Inflammation of the airways and lung parenchyma in COPD: role of T cells. , 2002, Chest.

[37]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[38]  Q. Hamid,et al.  IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. , 2001, The Journal of allergy and clinical immunology.

[39]  B. Balbi,et al.  Increased MCP-1 and MIP-1b in bronchoalveolar lavage fluid of chronic bronchitics , 1999 .

[40]  E. Silverman,et al.  Risk factors for the development of chronic obstructive pulmonary disease. , 1996, The Medical clinics of North America.

[41]  J. Bach.  Organ-specific autoimmunity. , 1995, Immunology series.

[42]  Buist As.  Standardization of spirometry. , 1987 .

[43]  K. Deome,et al.  THE ULTRAVIOLET SPECTROGRAPHIC EXAMINATION OF THE FAT FRACTION OF MOUSE MILK AND MAMMARY GLANDS. , 1942, Science.